|
DGFT initiates anti-dumping probe into sulphenamides accelerators imports from China, EU & USA
|
|
Shardul Nautiyal, Mumbai
March 17 , 2025
|
|
|
The Directorate General of Trade Remedies (DGTR) has initiated anti-dumping investigation concerning imports of sulphenamides accelerators originating and imported from China PR, the European Union, and the United States of America. The probe follows allegations of material injury to the domestic industry due to the influx of these imports at unfair prices.
Sulphenamides accelerators have applications in pharmaceutical research, including the development of new anti-bacterial agents by combining sulphenamide structures with other drug molecules to enhance their efficacy.
Interested parties, including exporters, importers, and domestic producers, have been invited to provide comments and propose additional Product Control Numbers (PCNs) within 15 days of receiving notification. The DGTR will conduct a thorough analysis to determine whether the imports are causing injury and whether anti-dumping duties should be imposed.
The decision on anti-dumping duties will significantly impact trade relations and pricing dynamics within the pharmaceutical industries. Stakeholders are urged to submit their responses within the stipulated timeline to aid the ongoing investigation.
In an official communication, joint director (FT) Rajiv Kumar Soni announced that the Authority has considered requests from interested parties for an extension of time to file Exporter’s Questionnaire Response (EQR), Importer’s Questionnaire Response (IQR), and Unrelated Importer’s Questionnaire Response (UQR) until March 22, 2025.
The case, designated as AD (01) - 49/2024, was initiated following an application from NOCIL Limited, which alleged that dumped imports of sulphenamides accelerators have caused significant material injury to the Indian industry. The request aims to impose anti-dumping duties on imports from the subject countries.
Under the Customs Tariff Act, 1975, and the Customs Tariff (Identification, Assessment, and Collection of Anti-Dumping Duty on Dumped Articles and for Determination of Injury) Rules, 1995, the DGTR will evaluate whether these imports are undercutting domestic production and affecting industry viability.
The scope of this investigation covers specific forms of sulphenamides accelerators primarily used in pharmaceutical research, particularly in antibacterial agent development.
The DGTR has preliminarily assessed that the domestically produced sulphenamides accelerators are like articles to the imported goods, making them interchangeable in industrial applications. Both products share essential physical and chemical characteristics, manufacturing processes, and commercial substitutability.
NOCIL Limited, which accounts for a significant share of domestic production, has been identified as the primary complainant. Another Indian manufacturer, Finorchem Limited, has also extended support for the investigation. The DGTR has affirmed that NOCIL Limited meets the requirements to be considered a domestic industry as per Rule 2(b) of the Anti-Dumping Rules.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|